Aquestive Therapeutics (AQST) vs Cumberland Pharmaceuticals (CPIX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Cumberland Pharmaceuticals (CPIX) has outperformed Aquestive Therapeutics (AQST) over the past year, gaining 90.2% versus a loss of 23.2%. Over five years, CPIX leads with a +154.7% price change compared with +23.0% for AQST. Aquestive Therapeutics is the larger company by market cap ($606.2 million vs $105.9 million), about 5.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AQST | CPIX |
|---|---|---|
| Share price | $4.83 | $7.07 |
| Market cap | $606.22M | $105.93M |
| 1-day change | +1.47% | +1.29% |
| YTD return | -26.32% | +75.38% |
| 1-year return | -23.23% | +90.19% |
| 5-year return | +23.00% | +154.74% |
| Forward P/E | — | 50.50 |
| EPS (TTM) | $-0.66 | $-0.62 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.55 | $9.28 |
| 52-week low | $2.93 | $1.85 |
| Distance from 52-week high | -36.03% | -23.81% |
| Analyst consensus | none | — |
| Avg. price target upside | +93.17% | — |
| Average volume | 2.68M | 88.03K |
| Shares outstanding | 125.51M | 14.98M |
| Employees | 147 | 88 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Aquestive Therapeutics is about 5.7 times larger than Cumberland Pharmaceuticals by market value ($606.22M vs $105.93M).
- CPIX has outperformed AQST by 113.4 percentage points over the past year.
About Aquestive Therapeutics
AQST stock →Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally.
Health Care · Biotechnology: Pharmaceutical Preparations · 147 employees
About Cumberland Pharmaceuticals
CPIX stock →Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment; Vaprisol, an injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; and Tacilia, an oral capsule for the treatment of H.
Health Care · Biotechnology: Pharmaceutical Preparations · 88 employees
AQST vs CPIX FAQ
Which is bigger, Aquestive Therapeutics or Cumberland Pharmaceuticals?
Aquestive Therapeutics (AQST) is larger, with a market capitalization of $606.22M compared with $105.93M for Cumberland Pharmaceuticals (CPIX).
Which stock has performed better over the past year, AQST or CPIX?
CPIX returned +90.19% over the past 12 months, compared with -23.23% for AQST (price return, excluding dividends). Past performance does not predict future results.
Are Aquestive Therapeutics and Cumberland Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.